Journal article
Determining Adenosine Deaminase 1 (ADA-1) Impact on Immune Memory and Durability as a Molecular Adjuvant in a SARS-CoV-2 DNA Vaccine Formulation
The Journal of immunology (1950), v 206(1_Supplement), pp 30-30.04
01 May 2021
Abstract
Abstract The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for coronavirus disease of 2019 (COVID-19), has infected millions of people causing a global pandemic. SARS-CoV-2 vaccines candidates have demonstrated acute immunogenicity and protection however, it has yet to be demonstrated whether natural or vaccine induced immunity against SARS-CoV-2 induces long term, protective immunity. In this study we sought to understand if adenosine deaminase (ADA), as a molecular adjuvant, can enhance immune memory and durability in the context of a SARS-CoV-2 DNA vaccine. Mice were immunized with a plasmid encoding for SARS-CoV-2 spike alone or in combination with plasmid encoded ADA. Subsequent B and T cell responses were measured until d60pi. In mice co-immunized with ADA, there were increased concentrations of spike receptor binding domain (RBD)-specific IgG in the sera which were found to bind RBD at an increased affinity as well as exhibit increased neutralization capability against SARS-CoV-2 pseudotyped viruses. Additionally, ADA co-immunized mice exhibited increased frequency of RBD specific memory B cells. In regard to T cell responses, mice co-immunized with ADA exhibited increased spike-specific IFN-γ, TNF-a and IL-2 as measured by flow cytometry and ELISpot. The ADA-enhanced anti-spike antibody durability over time was associated with increased frequencies of T follicular helper cells (TFH). Preliminary analysis supports that co-immunization with pADA impacts viral load in a SARS-CoV-2 infection model. These data suggest that ADA enhances immune memory and durability and supports further study with translational focus for enhancement of vaccines.
Metrics
23 Record Views
Details
- Title
- Determining Adenosine Deaminase 1 (ADA-1) Impact on Immune Memory and Durability as a Molecular Adjuvant in a SARS-CoV-2 DNA Vaccine Formulation
- Creators
- Gina Cusimano - Drexel UniversityEbony N. Gary - The Wistar InstituteMatt Bell - Drexel UniversityJennifer R Connors - Drexel UniversityNicholas J. Tursi - The Wistar InstituteShiyu Zhang - Drexel UniversityGabriela Canziani - Drexel UniversityBryce Warner - Public Health Agency of CanadaAli R. Ali - The Wistar InstituteBhavani Taramangalam - Drexel UniversityIrwin C. Chaiken - Drexel UniversitySarah Wootton - University of GuelphDavid Weiner - The Wistar InstituteDarwyn Kobasa - Public Health Agency of CanadaMichele A. Kutzler - Drexel UniversityElias K. Haddad - Drexel University
- Publication Details
- The Journal of immunology (1950), v 206(1_Supplement), pp 30-30.04
- Publisher
- American Association of Immunologists (AAI)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Biochemistry and Molecular Biology; Microbiology and Immunology; Medicine (Graduate); Infectious Diseases (and HIV Medicine)
- Other Identifier
- 991020524158104721